Our manufacturing capabilities are integral to our endeavour of bringing science to life and delivering high-quality products to patients worldwide.
We have invested ahead of the curve in operational excellence, automation, and quality-first systems across our 11 global world-class manufacturing facilities with relentless commitment to reliability, and regulatory excellence.
Across all our facilities, we have advanced capabilities to support the production of oral solids, semi-solids, liquids, nasal sprays, and injectables.
Manufacturing Sites
Quality-first approach
We believe that patient health and safety is paramount. This belief drives all our operations. We achieve high standards in product quality and safety through stringent processes, continuous investments in automation, lean systems, and real-time quality monitoring. Our capabilities across complex generics, injectables, respiratory devices, and topicals ensure every product that reaches patients is of the highest quality standards.
A resilient and responsible supply chain
A resilient supply chain is fundamental to delivering life-saving therapies to patients
worldwide — bridging the gap between scientific innovation and real-world access.
We have also made significant strides in digitizing key aspects of our supply chain,
enabling smarter demand forecasting, better inventory planning, and cost efficiency.
Manufacturing and supply chain are strategic levers of value creation, speed,
and trust.